A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial. Clara Fonteneau , Zailyn Tamayo , Ally Price , Lining Pan , Yvette Afriyie-Agyemang , Shriya Agrawal , Audrey Butler , Courtney Cail , Monica Calkins , Srinivas Chakilam , Kimberlee Forselius-Bielen , Geena Fram , Allea Frazier , Roberto Gil , Preetika Govil , David L Gray , Jack Grinband , Ruben C Gur , Natalka K Haubold , Zachary Heffernan , Larry Kegeles , Christian Kohler , Chenyang Lin , Jing Lu , Megan Mayer , Phuong Pham , Greg Perlman , Masih Rahmati , Mohini Ranganathan , Nicole P Santamauro , Christopher T Schutte , Alexandria Selloni , Jared Van Snellenberg , Toral Surti , Daniel H Wolf , Catrin Zharyy , TRANSCENDS Group , Anissa Abi-Dargham , Raquel E Gur , Jeffrey A Lieberman , Joshua T Kantrowitz , Alan Anticevic , Youngsun T Cho , John H Krystal medRxiv the preprint server for health sciences（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
